Peripheral nerve stimulation for trigeminal neuropathic pain

David A. Stidd, Adam Wuollet, Kirk Bowden, Theodore Price, Amol M Patwardhan, Steve Barker, Martin E Weinand, Jeffrey Annabi, Emil Annabi

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Facial pain is a complex disease with a number of possible etiologies. Trigeminal neuropathic pain (TNP) is defined as pain caused by a lesion or disease of the trigeminal branch of the peripheral nervous system resulting in chronic facial pain over the distribution of the injured nerve. First line treatment of TNP includes management with anticonvulsant medication (carbamazepine, phenytoin, gabapentin, etc.), baclofen, and analgesics. TNP, however, can be a condition difficult to adequately treat with medical management alone. Patients with TNP can suffer from significant morbidity as a result of inadequate treatment or the side effects of pharmacologic therapy. TNP refractory to medical management can be considered for treatment with a growing number of invasive procedures. Peripheral nerve stimulation (PNS) is a minimally invasive option that has been shown to effectively treat medically intractable TNP. We present a case series of common causes of TNP successfully treated with PNS with up to a 2 year follow-up. Only one patient required implantation of new electrode leads secondary to electrode migration. The patients in this case series continue to have significant symptomatic relief, demonstrating PNS as an effective treatment option for intractable TNP. Though there are no randomized trials, peripheral neuromodulation has been shown to be an effective means of treating TNP refractory to medical management in a growing number of case series. PNS is a safe procedure that can be performed even on patients that are not optimal surgical candidates and should be considered for patients suffering from TNP that have failed medical management.

Original languageEnglish (US)
Pages (from-to)27-33
Number of pages7
JournalPain Physician
Volume15
Issue number1
StatePublished - Jan 2012

Fingerprint

Neuralgia
Peripheral Nerves
Facial Pain
Electrodes
Therapeutics
Baclofen
Carbamazepine
Peripheral Nervous System
Phenytoin
Pain Management
Chronic Pain
Anticonvulsants
Analgesics
Morbidity
Pain

Keywords

  • Facial trauma
  • Intractable pain
  • Neuromodulation
  • Peripheral nerve stimulation
  • Postherpetic neuralgia
  • Trigeminal neuropathic pain

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Stidd, D. A., Wuollet, A., Bowden, K., Price, T., Patwardhan, A. M., Barker, S., ... Annabi, E. (2012). Peripheral nerve stimulation for trigeminal neuropathic pain. Pain Physician, 15(1), 27-33.

Peripheral nerve stimulation for trigeminal neuropathic pain. / Stidd, David A.; Wuollet, Adam; Bowden, Kirk; Price, Theodore; Patwardhan, Amol M; Barker, Steve; Weinand, Martin E; Annabi, Jeffrey; Annabi, Emil.

In: Pain Physician, Vol. 15, No. 1, 01.2012, p. 27-33.

Research output: Contribution to journalArticle

Stidd, DA, Wuollet, A, Bowden, K, Price, T, Patwardhan, AM, Barker, S, Weinand, ME, Annabi, J & Annabi, E 2012, 'Peripheral nerve stimulation for trigeminal neuropathic pain', Pain Physician, vol. 15, no. 1, pp. 27-33.
Stidd DA, Wuollet A, Bowden K, Price T, Patwardhan AM, Barker S et al. Peripheral nerve stimulation for trigeminal neuropathic pain. Pain Physician. 2012 Jan;15(1):27-33.
Stidd, David A. ; Wuollet, Adam ; Bowden, Kirk ; Price, Theodore ; Patwardhan, Amol M ; Barker, Steve ; Weinand, Martin E ; Annabi, Jeffrey ; Annabi, Emil. / Peripheral nerve stimulation for trigeminal neuropathic pain. In: Pain Physician. 2012 ; Vol. 15, No. 1. pp. 27-33.
@article{53c74be232624ddfb012c84d1fb7da30,
title = "Peripheral nerve stimulation for trigeminal neuropathic pain",
abstract = "Facial pain is a complex disease with a number of possible etiologies. Trigeminal neuropathic pain (TNP) is defined as pain caused by a lesion or disease of the trigeminal branch of the peripheral nervous system resulting in chronic facial pain over the distribution of the injured nerve. First line treatment of TNP includes management with anticonvulsant medication (carbamazepine, phenytoin, gabapentin, etc.), baclofen, and analgesics. TNP, however, can be a condition difficult to adequately treat with medical management alone. Patients with TNP can suffer from significant morbidity as a result of inadequate treatment or the side effects of pharmacologic therapy. TNP refractory to medical management can be considered for treatment with a growing number of invasive procedures. Peripheral nerve stimulation (PNS) is a minimally invasive option that has been shown to effectively treat medically intractable TNP. We present a case series of common causes of TNP successfully treated with PNS with up to a 2 year follow-up. Only one patient required implantation of new electrode leads secondary to electrode migration. The patients in this case series continue to have significant symptomatic relief, demonstrating PNS as an effective treatment option for intractable TNP. Though there are no randomized trials, peripheral neuromodulation has been shown to be an effective means of treating TNP refractory to medical management in a growing number of case series. PNS is a safe procedure that can be performed even on patients that are not optimal surgical candidates and should be considered for patients suffering from TNP that have failed medical management.",
keywords = "Facial trauma, Intractable pain, Neuromodulation, Peripheral nerve stimulation, Postherpetic neuralgia, Trigeminal neuropathic pain",
author = "Stidd, {David A.} and Adam Wuollet and Kirk Bowden and Theodore Price and Patwardhan, {Amol M} and Steve Barker and Weinand, {Martin E} and Jeffrey Annabi and Emil Annabi",
year = "2012",
month = "1",
language = "English (US)",
volume = "15",
pages = "27--33",
journal = "Pain Physician",
issn = "1533-3159",
publisher = "Association of Pain Management Anesthesiologists",
number = "1",

}

TY - JOUR

T1 - Peripheral nerve stimulation for trigeminal neuropathic pain

AU - Stidd, David A.

AU - Wuollet, Adam

AU - Bowden, Kirk

AU - Price, Theodore

AU - Patwardhan, Amol M

AU - Barker, Steve

AU - Weinand, Martin E

AU - Annabi, Jeffrey

AU - Annabi, Emil

PY - 2012/1

Y1 - 2012/1

N2 - Facial pain is a complex disease with a number of possible etiologies. Trigeminal neuropathic pain (TNP) is defined as pain caused by a lesion or disease of the trigeminal branch of the peripheral nervous system resulting in chronic facial pain over the distribution of the injured nerve. First line treatment of TNP includes management with anticonvulsant medication (carbamazepine, phenytoin, gabapentin, etc.), baclofen, and analgesics. TNP, however, can be a condition difficult to adequately treat with medical management alone. Patients with TNP can suffer from significant morbidity as a result of inadequate treatment or the side effects of pharmacologic therapy. TNP refractory to medical management can be considered for treatment with a growing number of invasive procedures. Peripheral nerve stimulation (PNS) is a minimally invasive option that has been shown to effectively treat medically intractable TNP. We present a case series of common causes of TNP successfully treated with PNS with up to a 2 year follow-up. Only one patient required implantation of new electrode leads secondary to electrode migration. The patients in this case series continue to have significant symptomatic relief, demonstrating PNS as an effective treatment option for intractable TNP. Though there are no randomized trials, peripheral neuromodulation has been shown to be an effective means of treating TNP refractory to medical management in a growing number of case series. PNS is a safe procedure that can be performed even on patients that are not optimal surgical candidates and should be considered for patients suffering from TNP that have failed medical management.

AB - Facial pain is a complex disease with a number of possible etiologies. Trigeminal neuropathic pain (TNP) is defined as pain caused by a lesion or disease of the trigeminal branch of the peripheral nervous system resulting in chronic facial pain over the distribution of the injured nerve. First line treatment of TNP includes management with anticonvulsant medication (carbamazepine, phenytoin, gabapentin, etc.), baclofen, and analgesics. TNP, however, can be a condition difficult to adequately treat with medical management alone. Patients with TNP can suffer from significant morbidity as a result of inadequate treatment or the side effects of pharmacologic therapy. TNP refractory to medical management can be considered for treatment with a growing number of invasive procedures. Peripheral nerve stimulation (PNS) is a minimally invasive option that has been shown to effectively treat medically intractable TNP. We present a case series of common causes of TNP successfully treated with PNS with up to a 2 year follow-up. Only one patient required implantation of new electrode leads secondary to electrode migration. The patients in this case series continue to have significant symptomatic relief, demonstrating PNS as an effective treatment option for intractable TNP. Though there are no randomized trials, peripheral neuromodulation has been shown to be an effective means of treating TNP refractory to medical management in a growing number of case series. PNS is a safe procedure that can be performed even on patients that are not optimal surgical candidates and should be considered for patients suffering from TNP that have failed medical management.

KW - Facial trauma

KW - Intractable pain

KW - Neuromodulation

KW - Peripheral nerve stimulation

KW - Postherpetic neuralgia

KW - Trigeminal neuropathic pain

UR - http://www.scopus.com/inward/record.url?scp=84856453536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856453536&partnerID=8YFLogxK

M3 - Article

C2 - 22270735

AN - SCOPUS:84856453536

VL - 15

SP - 27

EP - 33

JO - Pain Physician

JF - Pain Physician

SN - 1533-3159

IS - 1

ER -